Moringa leaf capsules benefits
Cardiac dystrophy is the result of reduced blood (oxygen) transport to the heart muscle occurs because of the narrowing of the blood vessels of the arteries of heart. Researchers found that moringa oleifera leaves extract and atenolol had a greater hypolipidaemic potential. This shows progressive metabolic control of moringa oleifera leaves extract on mechanisms involved in eradication of the lipids from the body. Researcher’s analysis data confirmed that consumption of these leaves may lead to reduction in the risk of hyperlipidemic symptoms and heart diseases. Alternatively these capsules have been used in clinical trials to study the effects on cardiac patients.
Glucose homeostasis derives equilibrium between glucose supply and its utilization. This equilibrium is physiologically, decided by level of circulating insulin and tissue responsiveness to insulin balance. Insulin is secreted in pancreatic islet β cells. It can stimulate glucose uptake and utilization of glucose by tissues, especially by adipose tissue, liver and skeletal muscle. Insulin can suppress gluconeogenesis in hepatocytes and stimulates lipogenesis. It is capable of inhibiting lipolysis in fat cells.
Moringa leaves powder capsules possess anti-inflammatory and analgesic property. They inhibit the production of prostaglandins and leukotrine. These are responsible for pain and inflammation. It shows disease modifying effect means. It can slow down the progress of the disease modifying effect. It can slow down the progress of disease, stop further damage to the joint to recover on its own.
Effect of moringa leaf extract or powder in chronic hyperglycemia or hyperlipidemia was studied and analyzed. Studies focused on mode of administration therapy models, galenic formulation, dosage, treatment duration and measurable biochemical outcomes. Hyperglycemia enhances LDL particles glycation, a change that extends their life in circulation. LDL particles are prone to oxidation and are effective initiators of atherogenesis process and its cardiovascular damages. Diabetes-associated retinopathy, neuropathy, and nephropathy are some of the results of these potent damages.
Oxidative process that leads to oxLDL production also contributes to atherogenesis, as this modified lipoprotein and its by-products (oxysterols and oxPL) act as monocytes chemo attractants and VSMC mitogens. Clinical complications of this process include a narrowing of the arterial lumen. Formation of circulating thrombi and plaque rupture are few other clinical conditions. These complications could lead to coronary artery disease (CAD), thrombo-embolic stroke, myocardial infarction and peripheral artery disease.
It indicated the content in fibers, phytosterols as well in anti-oxidant and anti-inflammatory activities be evaluated and documented in moringa oleifera galenic formulations destined to the treatment of atherosclerosis or diabetes. Few clinical trials on diabetic and heart patients have been conducted over the past few years. This has proved that moringa leaf powder capsules at prescribed dosage have given good results.